...
首页> 外文期刊>Journal of biomolecular screening: The official journal of the Society for Biomolecular Screening >Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists
【24h】

Integrating High-Content Analysis into a Multiplexed Screening Approach to Identify and Characterize GPCR Agonists

机译:将高内涵分析整合到多重筛选方法中以鉴定和表征GPCR激动剂

获取原文
获取原文并翻译 | 示例
           

摘要

G protein–coupled receptors (GPCRs) are one of the most popular and proven target classes for therapeutic intervention. The increased appreciation for allosteric modulation, receptor oligomerization, and biased agonism has led to the development of new assay platforms that seek to capitalize on these aspects of GPCR biology. High-content screening is particularly well suited for GPCR drug discovery given the ability to image and quantify changes in multiple cellular parameters, to resolve subcellular structures, and to monitor events within a physiologically relevant environment. Focusing on the sphingosine-1-phosphate (S1P1) receptor, we evaluated the utility of high-content approaches in hit identification efforts by developing and applying assays to monitor β-arrestin translocation, GPCR internalization, and GPCR recycling kinetics. Using these approaches in combination with more traditional GPCR screening assays, we identified compounds whose unique pharmacological profiles would have gone unnoticed if using a single platform. In addition, we identified a compound that induces an atypical pattern of β-arrestin translocation and GPCR recycling kinetics. Our results highlight the value of high-content imaging in GPCR drug discovery efforts and emphasize the value of a multiassay approach to study pharmacological properties of compounds of interest.
机译:G蛋白偶联受体(GPCR)是治疗干预中最流行和最成熟的靶标类型之一。对变构调节,受体寡聚和偏向激动的日益增长的赏识导致了新的测定平台的开发,这些平台试图利用GPCR生物学的这些方面。鉴于能够对多种细胞参数的变化进行成像和量化,解析亚细胞结构以及监测生理相关环境中的事件,高内涵筛选特别适合于GPCR药物发现。我们着眼于鞘氨醇-1-磷酸(S1P1)受体,通过开发和应用检测β-arrestin易位,GPCR内在化和GPCR循环动力学的方法,我们评估了高含量方法在命中鉴定工作中的实用性。通过将这些方法与更传统的GPCR筛选分析结合使用,我们确定了如果使用单一平台,其独特药理学特征将不会被发现的化合物。此外,我们鉴定了一种诱导β-arrestin转运和GPCR循环动力学的非典型模式的化合物。我们的结果突出了高含量成像在GPCR药物发现工作中的价值,并强调了一种用于研究目标化合物的药理特性的多重分析方法的价值。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号